Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

[Hungarian data on inflammatory bowel diseases: analytical data on ulcerative colistis].

Miheller P, Nagy F, Palatka K, Altorjay I, Horváth G, Lőrinczy K, Újszászy L, Virányi Z, Szepes A, Molnár T, Farkas K, Szepes Z, Nyári T, Wittmann T, Tulassay Z.

Orv Hetil. 2012 May 6;153(18):702-12. doi: 10.1556/OH.2012.29361. Hungarian.

PMID:
22547465
2.

Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study.

Aronson D, Verbalis JG, Mueller M, Krum H; DILIPO investigators.

Eur J Heart Fail. 2011 Mar;13(3):327-36. doi: 10.1093/eurjhf/hfq226. Epub 2011 Jan 3.

3.

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.

Kruis W, Jonaitis L, Pokrotnieks J, Mikhailova TL, Horynski M, Bátovský M, Lozynsky YS, Zakharash Y, Rácz I, Kull K, Vcev A, Faszczyk M, Dilger K, Greinwald R, Mueller R; International Salofalk OD Study Group.

Aliment Pharmacol Ther. 2011 Feb;33(3):313-22. doi: 10.1111/j.1365-2036.2010.04537.x. Epub 2010 Dec 8.

4.

Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.

Tromm A, Bunganič I, Tomsová E, Tulassay Z, Lukáš M, Kykal J, Bátovský M, Fixa B, Gabalec L, Safadi R, Kramm HJ, Altorjay I, Löhr H, Koutroubakis I, Bar-Meir S, Stimac D, Schäffeler E, Glasmacher C, Dilger K, Mohrbacher R, Greinwald R; International Budenofalk Study Group.

Gastroenterology. 2011 Feb;140(2):425-434.e1; quiz e13-4. doi: 10.1053/j.gastro.2010.11.004. Epub 2010 Nov 9.

PMID:
21070781
5.

Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.

Ginès P, Wong F, Watson H, Terg R, Bruha R, Zarski JP, Dudley F; NormoCAT Study Investigators.

Aliment Pharmacol Ther. 2010 Apr;31(8):834-45. doi: 10.1111/j.1365-2036.2010.04236.x. Epub 2010 Jan 22.

6.

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study.

Miheller P, Lakatos PL, Horváth G, Molnár T, Szamosi T, Czeglédi Z, Salamon A, Czimmer J, Rumi G, Palatka K, Papp M, Jakab Z, Szabó A, Gelley A, Lakatos L, Barta Z, Balázs C, Rácz I, Zeher M, Döbrönte Z, Altorjay I, Hunyady B, Simon L, Papp J, Banai J, Nagy F, Lonovics J, Ujszászy L, Muzes G, Herszényi L, Tulassay Z.

BMC Gastroenterol. 2009 Sep 10;9:66. doi: 10.1186/1471-230X-9-66.

7.

Effect of dronedarone on cardiovascular events in atrial fibrillation.

Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ; ATHENA Investigators.

N Engl J Med. 2009 Feb 12;360(7):668-78. doi: 10.1056/NEJMoa0803778. Erratum in: N Engl J Med. 2009 Jun 4;360(23):2487. N Engl J Med. 2011 Apr 14;364(15):1481.

8.

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.

Kruis W, Kiudelis G, Rácz I, Gorelov IA, Pokrotnieks J, Horynski M, Batovsky M, Kykal J, Boehm S, Greinwald R, Mueller R; International Salofalk OD Study Group.

Gut. 2009 Feb;58(2):233-40. doi: 10.1136/gut.2008.154302. Epub 2008 Oct 2.

9.

Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.

Davies M, Lavalle-González F, Storms F, Gomis R; AT.LANTUS Study Group.

Diabetes Obes Metab. 2008 May;10(5):387-99. doi: 10.1111/j.1463-1326.2008.00873.x. Epub 2008 Mar 18.

PMID:
18355327
10.

Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study.

Kulich KR, Madisch A, Pacini F, Piqué JM, Regula J, Van Rensburg CJ, Ujszászy L, Carlsson J, Halling K, Wiklund IK.

Health Qual Life Outcomes. 2008 Jan 31;6:12. doi: 10.1186/1477-7525-6-12.

11.

Psychometric validation of the Hungarian translation of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with reflux disease.

Kulich RK, Ujszászy L, Tóth GT, Bárány L, Carlsson J, Wiklund I.

Orv Hetil. 2004 Mar 28;145(13 Suppl 2):723-9, 739-44. English, Hungarian.

PMID:
15125325
12.

Burden of illness in patients with reflux disease--evidence from a recent comparative methodological study in Hungary.

Ujszászy L, Kulich RK, Tóth GT, Bárány L, Carlsson J, Wiklund I.

Orv Hetil. 2004 Mar 28;145(13 Suppl 2):717-22, 733-8. English, Hungarian.

PMID:
15125324
13.

[Comparison of the effectiveness and tolerability of the saccharosum-sennosid-B solution and sodium-picosulfate in preparation for colonoscopy. Prospective, multicenter, randomized study].

Demeter P, Ujszászy L, Sike R, Tóth GT, Grenda A, Kiss GG, Novák J, Gurzó Z, Csiki Z.

Orv Hetil. 2003 Aug 10;144(32):1587-90. Hungarian.

PMID:
12974184
14.

[Cutaneous and mucosal manifestations of inflammatory bowel diseases].

Károlyi Z, Erós N, Ujszászy L, Nagy G.

Orv Hetil. 2000 Jun 18;141(25):1391-5. Review. Hungarian.

PMID:
10934882
15.

The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer.

Malfertheiner P, Bayerdörffer E, Diete U, Gil J, Lind T, Misiuna P, O'Morain C, Sipponen P, Spiller RC, Stasiewicz J, Treichel H, Ujszászy L, Unge P, Zanten SJ, Zeijlon L.

Aliment Pharmacol Ther. 1999 Jun;13(6):703-12.

16.

[Complex screening of family members at risk for familial adenomatous polyposis].

Kristóf T, Tóth T, Ujszászy L, Juhász L, Korompai K, Minik K, Papp Z.

Orv Hetil. 1997 Dec 14;138(50):3159-64. Review. Hungarian.

PMID:
9446080
17.

Presymptomatic diagnosis of familial colon polyposis.

Tóth T, Kristóf T, Ujszászy L, Gerö G, Nagy B, Papp Z.

Acta Biol Hung. 1997;48(3):377-83.

PMID:
9406616
18.

Screening for colorectal cancer in a Hungarian county.

Ujszászy L, Prónay G, Nagy G, Kovács J, Libor J, Minik K.

Endoscopy. 1985 May;17(3):109-12.

PMID:
4006870
19.

[Therapeutic experience with ulcerative colitis and Crohn disease].

Nagy G, Prónay G, Ujszászy L.

Orv Hetil. 1985 Jan 6;126(1):17-20, 23-4. Hungarian. No abstract available.

PMID:
2857480
20.

Therapeutical experiments in ulcerative colitis and Crohn's disease.

Nagy G, Prónay G, Ujszászy L.

Acta Med Hung. 1985;42(3-4):163-74.

PMID:
2869469

Supplemental Content

Loading ...
Support Center